Assessment of the potential for oritavancin MIC changes among Staphylococcus aureus nasal carriage isolates following systemic oritavancin treatment in a phase 2 study in patients with acute bacterial skin and skin-structure infections.

J Glob Antimicrob Resist

The Medicines Company, 7170 Frederick Banting, Ville Saint Laurent, Quebec, H4S 2A1, Canada.

Published: June 2017

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jgar.2017.01.003	DOI Listing

Publication Analysis

assessment potential

potential oritavancin

oritavancin mic

mic changes

changes staphylococcus

staphylococcus aureus

aureus nasal

nasal carriage

carriage isolates

isolates systemic

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!